Australia markets closed

NexImmune, Inc. (NEXI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.3200+0.2000 (+6.41%)
At close: 04:00PM EDT
3.3700 +0.05 (+1.51%)
After hours: 06:26PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
19,282
19,282
47,148
37,456
17,839
Selling general and administrative
13,001
13,001
15,934
15,799
10,012
Total operating expenses
32,283
32,283
63,083
53,256
27,851
Operating income or loss
-32,283
-32,283
-63,083
-53,256
-27,851
Interest expense
-
-
0
905.326
1,683
Total other income/expenses net
-759.934
-759.934
-87.682
3,207
-352.507
Income before tax
-32,344
-32,344
-62,506
-50,902
-29,866
Income from continuing operations
-32,344
-32,344
-62,506
-50,902
-29,866
Net income
-32,344
-32,344
-62,506
-50,902
-29,866
Net income available to common shareholders
-32,344
-32,344
-62,506
-51,279
-33,147
Basic EPS
-42.05
-30.82
-64.95
-63.50
-41.92
Diluted EPS
-42.05
-30.82
-64.95
-63.50
-41.92
Basic average shares
1,045
1,049
962.364
807.445
790.695
Diluted average shares
1,045
1,049
962.364
807.445
790.695